|
Market Cap (24-Jun) $4,172,944 (725th) |
Close (30-Jun) $0.260 |
Volume (30-Jun) 239,872 |
Shortsold (5-Oct) 64,772 (0.03%) (542nd) |
|
52w High $0.035 |
52w Low $0.012 |
P/E 11.29 |
EPS -0.06 |
UBI released this announcement to the ASX on 20 April 2023, 8:12. The announcement is marked as price sensitive, and is 2 page(s) in length and 136.97kb in size.
You can view all announcements from UBI and see how they appear on a price chart on the announcements page.
At the date of this announcement, UBI was 0.029% short sold according to ASIC data. It was ranked the 534th most shorted stock on the ASX. It remains ranked 542nd as of the latest reported data (05 October 2023).
| Other Recent Announcements from UBI | |
|---|---|
| Results of 2023 Annual General meeting | 22 May 2023, 12:14 |
| CEO's AGM address to Securityholders | 22 May 2023, 8:33 |
| Q1 2023 Results | 11 May 2023, 15:41 |
| UBI launch sixth new Sentia Test | 20 April 2023, 8:12 |
| Notice of Meeting/Proxy Statement | 11 April 2023, 8:15 |
| UBI submits Xprecia Prime 510K Application to FDA | 24 March 2023, 10:45 |
| Appendix 3Y - Graham McLean | 16 March 2023, 8:40 |
You must be logged in to post a reply.
Universal Biosensors, Inc 